Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Marinus Pharmaceuticals Inc
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Marinus Pharmaceuticals Inc since year 2005.
Table 2 shows the detailed insider transactions of Marinus Pharmaceuticals Inc since 2005.
The reporting company's ticker symbol is MRNS. The reporting company's CIK number is 1267813.
The total value of stock buying since 2005 is $19,363,416.
The total value of stock sales since 2005 is $2,362,794.
The total value of stock option exercises since 2005 is $236,728.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2016-08-08||Canaan Partners Vii Llc (10% Owner)||Sale||19,950||1.50||29,925|
|2016-08-05||Canaan Partners Vii Llc (10% Owner)||Sale||129,204||1.50||193,806|
|2016-08-04||Canaan Partners Vii Llc (10% Owner)||Sale||3,329||1.50||4,993|
|2016-08-03||Canaan Partners Vii Llc (10% Owner)||Sale||142,254||1.50||213,381|
|2016-07-29||Canaan Partners Vii Llc (10% Owner)||Sale||24,540||1.71||41,963|
|2016-07-27||Canaan Partners Vii Llc (10% Owner)||Sale||209||1.80||376|
|2016-07-26||Canaan Partners Vii Llc (10% Owner)||Sale||20,380||1.81||36,887|
|2016-07-25||Canaan Partners Vii Llc (10% Owner)||Sale||137,617||1.86||255,967|
|2016-07-22||Canaan Partners Vii Llc (10% Owner)||Sale||133,133||1.94||258,278|
|2015-09-28||Bloch Stephen M (Director)||Option Ex||39,550||1.04||41,132|
|2015-07-16||Mayleben Timothy M (Director)||Option Ex||42,550||1.04||44,252|
|2015-07-01||Cashman Christopher Michael (President and CEO)||Option Ex||14,086||1.04||14,649|
|2015-06-10||Bloch Stephen M (Director)||Option Ex||3,000||1.04||3,120|
|2015-04-21||Farfel Gail M (Chief Clinical Dev & Reg Offic)||Sale||30,000||9.48||284,520|
|2015-04-21||Farfel Gail M (Chief Clinical Dev & Reg Offic)||Option Ex||30,000||1.04||31,200|
|2015-03-06||Cashman Christopher Michael (PRESIDENT AND CEO)||Option Ex||17,608||1.04||18,312|
|2014-10-08||Cashman Christopher Michael (PRESIDENT AND CEO)||Option Ex||80,830||1.04||84,063|
|2014-08-05||Canaan Partners Vii Llc (Director)||Buy||625,000||8.00||5,000,000|
|2014-08-05||Bloch Stephen M (Director)||Buy||625,000||8.00||5,000,000|
|2014-08-05||Powell Michael (10% Owner)||Buy||750,683||8.00||6,005,464|
|2014-08-05||Vitullo Nicole (Director)||Buy||419,744||8.00||3,357,952|
Insider trading activities including stock purchases, stock sales, and option exercises of MRNS listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Marinus Pharmaceuticals Inc (symbol MRNS, CIK number 1267813) see the Securities and Exchange Commission (SEC) website.